Continuous monitoring of heart failure biomarkers using advanced sensor technology
Reagentless Sensor Technologies For Continuous Monitoring of Heart Failure Biomarkers
This study is working on new technology that can easily and continuously check important heart health markers for people with heart failure, helping doctors keep a closer eye on patients and make better treatment decisions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11026445 on NIH RePORTER |
What this research studies
This research focuses on developing innovative sensor technologies that can continuously monitor biomarkers associated with heart failure. By creating a reagent-free and enzyme-free electrochemical system, the project aims to provide real-time data on critical biomolecules without the need for complex sample processing. This technology will be adapted specifically for heart failure markers, allowing for remote monitoring of patients at risk for this progressive condition. The goal is to enhance patient management and improve outcomes through better risk assessment and timely interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are at risk for or currently experiencing heart failure.
Not a fit: Patients with heart failure who are not able to use wearable technology or those with conditions that prevent continuous monitoring may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management of heart failure through continuous and accurate monitoring of biomarkers.
How similar studies have performed: Previous research has shown promise in using similar sensor technologies for biomarker monitoring, indicating potential for success in this novel application.
Where this research is happening
Chicago, UNITED STATES
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Kelley, Shana O — Northwestern University
- Study coordinator: Kelley, Shana O
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.